• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Atypical presentation of late-onset Tay-Sachs disease.晚发性泰萨二氏病的非典型表现。
Muscle Nerve. 2014 May;49(5):768-71. doi: 10.1002/mus.24146. Epub 2014 Feb 24.
2
Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.晚发性泰萨二氏症候群呈现出神经肌肉表型:病例系列。
Eur J Neurol. 2024 Jan;31(1):e16069. doi: 10.1111/ene.16069. Epub 2023 Sep 27.
3
Novel HEXA variants in Korean children with Tay-Sachs disease with regression of neurodevelopment from infancy.新型 HEXA 变异导致韩国婴儿期发病的泰萨二氏症患儿神经发育倒退。
Mol Genet Genomic Med. 2021 Jun;9(6):e1677. doi: 10.1002/mgg3.1677. Epub 2021 Apr 3.
4
Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.肌萎缩、小脑功能障碍和精神疾病是 14 名捷克晚发性泰萨氏症患者的主要症状。
J Neurol. 2019 Aug;266(8):1953-1959. doi: 10.1007/s00415-019-09364-3. Epub 2019 May 10.
5
Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.从视频系列和文献回顾中诊断晚期泰-萨克斯病患者的技巧。
Tremor Other Hyperkinet Mov (N Y). 2022 Dec 27;12:34. doi: 10.5334/tohm.726. eCollection 2022.
6
Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis.提高非犹太人群中泰萨氏症携带者筛查的准确性:HEXA 酶和 DNA 序列分析 34 名携带者和 6 名迟发性患者。
Pediatr Res. 2010 Feb;67(2):217-20. doi: 10.1203/PDR.0b013e3181c6e318.
7
Tay-Sachs disease in an Arab family due to c.78G>A HEXA nonsense mutation encoding a p.W26X early truncation enzyme peptide.一个阿拉伯家族的泰萨氏症是由于 c.78G>A HEXA 无义突变导致编码 p.W26X 早期截断酶肽。
Mol Genet Metab. 2011 Dec;104(4):700-2. doi: 10.1016/j.ymgme.2011.09.013. Epub 2011 Sep 16.
8
Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.巴西非典型泰-萨克斯病的诊断与分子特征分析
J Child Neurol. 2006 Jun;21(6):540-4. doi: 10.1177/08830738060210061101.
9
Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.迟发性泰-萨克斯病:21例患者的表型特征及基因型相关性
Genet Med. 2005 Feb;7(2):119-23. doi: 10.1097/01.gim.0000154300.84107.75.
10
Cerebellar atrophy and muscle weakness: late-onset Tay-Sachs disease outside Jewish populations.小脑萎缩与肌肉无力:非犹太人群中的迟发性泰-萨克斯病
BMJ Case Rep. 2016 Mar 31;2016:bcr2016214634. doi: 10.1136/bcr-2016-214634.

引用本文的文献

1
Late-onset GM2 gangliosidosis: magnetic resonance imaging, diffusion tensor imaging, and correlational fiber tractography differentiate Tay-Sachs and Sandhoff diseases.迟发性GM2神经节苷脂贮积症:磁共振成像、扩散张量成像及相关纤维束成像鉴别泰-萨克斯病和桑德霍夫病
J Neurol. 2025 Apr 23;272(5):355. doi: 10.1007/s00415-025-13091-3.
2
Tay-Sachs and Sandhoff Diseases: Diffusion tensor imaging and correlational fiber tractography findings differentiate late-onset GM2 Gangliosidosis.泰-萨克斯病和桑德霍夫病:扩散张量成像及相关纤维束成像结果可鉴别迟发型GM2神经节苷脂沉积症。
medRxiv. 2024 Dec 16:2024.12.13.24318793. doi: 10.1101/2024.12.13.24318793.
3
Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late-onset Tay-Sachs disease.定量脑形态测量学确定了晚发性泰-萨克斯病患者小脑、皮质及皮质下灰质和白质萎缩。
J Inherit Metab Dis. 2024 Mar;47(2):327-339. doi: 10.1002/jimd.12700. Epub 2023 Dec 19.
4
Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.从视频系列和文献回顾中诊断晚期泰-萨克斯病患者的技巧。
Tremor Other Hyperkinet Mov (N Y). 2022 Dec 27;12:34. doi: 10.5334/tohm.726. eCollection 2022.
5
Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.桥小脑萎缩是晚发型泰-萨克斯病的标志性神经影像学表现。
Neurol Sci. 2022 May;43(5):3273-3281. doi: 10.1007/s10072-021-05757-3. Epub 2021 Nov 20.
6
Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis.磁共振成像和波谱在晚发型 GM2 神经节苷脂贮积症中的应用。
Mol Genet Metab. 2021 Aug;133(4):386-396. doi: 10.1016/j.ymgme.2021.06.008. Epub 2021 Jun 24.
7
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease).移动医疗和可穿戴技术在晚发型 GM2 神经节苷脂病(泰萨二氏病和桑德霍夫病)中的可行性研究。
Orphanet J Rare Dis. 2020 Aug 3;15(1):199. doi: 10.1186/s13023-020-01473-x.
8
New Approaches to Tay-Sachs Disease Therapy.泰-萨克斯病治疗的新方法。
Front Physiol. 2018 Nov 20;9:1663. doi: 10.3389/fphys.2018.01663. eCollection 2018.
9
Current concepts in the neuropathogenesis of mucolipidosis type IV.目前关于黏脂贮积症 IV 型的神经发病机制的概念。
J Neurochem. 2019 Mar;148(5):669-689. doi: 10.1111/jnc.14462. Epub 2018 Aug 30.
10
Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction.SNX14基因的双等位基因突变会导致一种伴有综合征的小脑萎缩和溶酶体-自噬体功能障碍。
Nat Genet. 2015 May;47(5):528-34. doi: 10.1038/ng.3256. Epub 2015 Apr 6.

本文引用的文献

1
Cerebellar ataxia with SYNE1 mutation accompanying motor neuron disease.伴有运动神经元病的SYNE1突变型小脑共济失调
Neurology. 2013 Feb 5;80(6):600-1. doi: 10.1212/WNL.0b013e3182815529. Epub 2013 Jan 16.
2
The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives.重新审视 Brown-Vialetto-Van Laere 和 Fazio Londe 综合征:自然病史、遗传学、治疗和未来展望。
Orphanet J Rare Dis. 2012 Oct 29;7:83. doi: 10.1186/1750-1172-7-83.
3
[Spinocerebellar ataxia type 36 (nicknamed Asidan)].36型脊髓小脑共济失调(昵称阿西丹)
Brain Nerve. 2012 Aug;64(8):937-41.
4
Spinal muscular atrophy.脊髓性肌萎缩症。
Orphanet J Rare Dis. 2011 Nov 2;6:71. doi: 10.1186/1750-1172-6-71.
5
Three spinocerebellar ataxia type 2 siblings with ataxia, parkinsonism, and motor neuronopathy.三名患有共济失调、帕金森综合征和运动神经元病的2型脊髓小脑共济失调同胞。
Intern Med. 2011;50(13):1429-32. doi: 10.2169/internalmedicine.50.5262. Epub 2011 Jul 1.
6
Machado-Joseph Disease: from first descriptions to new perspectives.马查多-约瑟夫病:从最初的描述到新视角。
Orphanet J Rare Dis. 2011 Jun 2;6:35. doi: 10.1186/1750-1172-6-35.
7
An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants).吡嘧司特治疗慢性 GM2 神经节苷脂病(Tay-Sachs 或桑德霍夫变异型)患者的开放标签 I/II 期临床试验。
Mol Genet Metab. 2011 Jan;102(1):6-12. doi: 10.1016/j.ymgme.2010.09.004. Epub 2010 Sep 17.
8
New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype.伴有小脑或下运动神经元表型的成人发病型桑德霍夫病新病例。
J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):968-72. doi: 10.1136/jnnp.2009.177089.
9
Progressive muscular atrophy and other lower motor neuron syndromes of adults.成人进行性肌萎缩及其他下运动神经元综合征
Muscle Nerve. 2010 Feb;41(2):161-5. doi: 10.1002/mus.21565.
10
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment.米格鲁司他治疗晚发性泰-萨克斯病:一项为期12个月的随机对照临床研究及24个月的延长治疗
Genet Med. 2009 Jun;11(6):425-33. doi: 10.1097/GIM.0b013e3181a1b5c5.

晚发性泰萨二氏病的非典型表现。

Atypical presentation of late-onset Tay-Sachs disease.

机构信息

Department of Neurology, Beth Israel Medical Center, New York, New York, USA; University of Pennsylvania, Parkinson Disease and Movement Disorders Center, 330 S. 9th Street, 2nd Floor, Suite 219, Philadelphia, Pennsylvania, 19107, USA.

出版信息

Muscle Nerve. 2014 May;49(5):768-71. doi: 10.1002/mus.24146. Epub 2014 Feb 24.

DOI:10.1002/mus.24146
PMID:24327357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4346308/
Abstract

INTRODUCTION

Late-onset Tay-Sachs disease (LOTS) is a lysosomal storage disease caused by deficient Beta-hexosaminidase A activity.

METHODS

We describe a 53-year-old woman who presented with adult-onset leg weakness, and whose initial diagnosis was progressive muscular atrophy without identifiable etiology. Development of cerebellar ataxia in mid-life prompted reassessment.

RESULTS

Beta-hexosaminidase A quantification assay demonstrated absence of the isozyme. Genetic testing identified compound heterozygous mutations in the HEXA gene, confirming the diagnosis of LOTS.

CONCLUSIONS

The phenotypic spectrum of LOTS includes motor neuronopathy, ataxia, choreoathetosis, neuropathy, and psychiatric symptoms in various combinations. This patient highlights the emergence of different clinical features over many years and emphasizes the need to consider LOTS in the differential diagnosis of progressive muscular atrophy.

摘要

简介

晚发性泰萨二氏症(LOTS)是一种溶酶体贮积病,由β-己糖胺酶 A 活性缺乏引起。

方法

我们描述了一位 53 岁女性,她表现为成年起病的下肢无力,最初的诊断为特发性进行性肌萎缩。中年时出现小脑共济失调促使我们重新评估。

结果

β-己糖胺酶 A 定量测定显示同工酶缺失。基因检测确定 HEXA 基因的复合杂合突变,确诊 LOTS。

结论

LOTS 的表型谱包括运动神经元病、共济失调、舞蹈手足徐动症、神经病和各种组合的精神症状。该患者突出了多年来不同临床表现的出现,并强调了在进行性肌萎缩的鉴别诊断中需要考虑 LOTS。